<p>After releasing its first quarter financials, J&J's stock fell over 3%. Is it a buy? In this episode, we dig into the quarter's highlights and low-lights to find out.</p>

After releasing its first quarter financials, J&J's stock fell over 3%. Is it a buy? In this episode, we dig into the quarter's highlights and low-lights to find out.

<p>After releasing its first quarter financials,&nbsp;J&amp;J's stock&nbsp;fell over&nbsp;3%. Is it a buy? In this episode, we dig into the&nbsp;quarter's&nbsp;highlights and&nbsp;low-lights to find out.</p>

Healthcare: Were Johnson & Johnson's Earnings Really That Bad?

Healthcare, technology, energy, consumer goods, and more. Every day, Motley Fool analysts break down a specific industry and the stocks making headlines. Questions? Comments? Email us at IndustryFocus@fool.com.

Share Healthcare: Were Johnson & Johnson's Earnings Really That Bad?

Sign up to save your podcasts

Healthcare: Were Johnson & Johnson's Earnings Really That Bad?

Healthcare: Were Johnson & Johnson's Earnings Really That Bad?